Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Atlas Venture
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Atlas Venture Similar startupsby what they do, their industry and backers
Correctors and Potentiators for Autosomal Dominant Polycystic Kidney Disease (ADPKD). Transforming the Treatment of ADPKD.
Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation.
Procarta Biosystems Ltd aims to revolutionise the treatment of serious and life-threatening infection through the development of innovative…
Technology. Dreamfold develops generative AI models to unlock more effective therapies for cancer, immune diseases, and other serious…
MixerBox Blog. Remix Possibilities to Help People Live Easier.
Pioneering a new class of allosteric medicines for the treatment of autoimmune disease. At HotSpot Therapeutics, we are pioneering a new…
News
Matchpoint Therapeutics Announces Exclusive Option and License Agreement with Novartis to Develop Oral Inhibitors for Multiple Inflammatory Diseases
-Matchpoint to receive up to $60 million in upfront payment and research funding, with up to $1 billion in total potential payments, including option exercise fee, development and commercial milestones -Matchpoint will lead all research activities through
Read more
Report
Timmerman Report: Matchpoint gets $100M to take covalent binders into autoimmune disease
The post Timmerman Report: Matchpoint gets $100M to take covalent binders into autoimmune disease appeared first on Matchpoint Therapeutics.
Read more
Report
BioSpace: Sanofi-backed Matchpoint launches with $100M for precision covalent medicines
The post BioSpace: Sanofi-backed Matchpoint launches with $100M for precision covalent medicines appeared first on Matchpoint Therapeutics.
Read more
Report
BioCentury: Matchpoint: a toolkit to create covalent therapies for immunology
The post BioCentury: Matchpoint: a toolkit to create covalent therapies for immunology appeared first on Matchpoint Therapeutics.
Read more
Report
Matchpoint: a toolkit to create covalent therapies for immunology
With $100 million in early funding from VCs, Matchpoint will deploy a chemistry and computational toolkit to advance a pipeline of covalent small mole...
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Watertown
United States
Regional office
Watertown